公告提醒：愛必信所有產(chǎn)品和服務(wù)僅用于科學(xué)研究，不用于臨床應(yīng)用及其他用途提供產(chǎn)品和服務(wù)（也不為任何個人提供產(chǎn)品和服務(wù)）!

抑制劑描述：

產(chǎn)品名稱：FH535

產(chǎn)品別名：FH 535; FH-535

英文別名：FH 535;FH-535

靶點(diǎn)：Wnt/β-catenin；PPARγ；PPARδ

CAS：108409-83-2

純度：98%

外觀：Yellow solid

保存方法：store at -20℃ for one year（Powder）； in DMSO or others solvent store at 2-4℃ for two weeks, at -20℃ for six months.

描述：

FH535 is a compound that suppresses both Wnt/beta-catenin and peroxisome proliferator-activated receptor (PPAR) signaling.

溶解性：DMSO ：72mg/ml(199.34 mM)

體外研究：

FH535 antagonizes β-Catenin/Tcf–mediated transcription, and inhibits recruitment of the coactivators GRIP1 and β-catenin to PPARδ and PPARγ. FH535 shows selective anti-proliferation effect on some cancer cells expressing high or active Wnt/β-catenin pathway. FH535 increases cigarette smoke condensate cytotoxicity, and causes changes in β-catenin and EGR-1 signaling. FH535 has potential therapeutic value in treatment of liver cancer by targeting liver cancer stem cells and hepatocellular carcinoma cell lines.

體內(nèi)研究：FH535 (25 mg/kg, i.p.) exhibits an anti-tumor effect on pancreatic cancer xenografts in mice. FH535 also represses angiogenesis in pancreatic cancer xenografts.

產(chǎn)品信息訂購：

產(chǎn)品更多信息請進(jìn)入愛必信網(wǎng)站咨詢